相关实验视频
Updated: Sep 14, 2025
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.3K
不同族群的炎症性肠病患者的临床特征和长期结果:一个病例对照研究
Nour Ealiwa1, Waleed Alamour2, Muhammad Abu-Tailakh3
1Goldman Medical School, Faculty of Health Sciences, Ben Gurion University of the Negev.
European journal of gastroenterology & hepatology
|July 21, 2025
概括
与犹太患者相比,阿拉伯贝都因炎症性肠病 (IBD) 患者表现出明显的临床特征和较差的结果,需要量身定制的医疗保健策略来改善访问和支持.
科学领域:
- 胃肠病学 胃肠病学
- 临床医学 临床医学
- 流行病学 流行病学
背景情况:
- 炎症性肠病 (IBD) 包括慢性胃肠炎症,影响结肠和小肠.
- 在全球范围内,IBD患病率和结果存在显著的种族差异.
- 尼格夫地区为比较阿拉伯贝都因 (BA) 和犹太人口之间的IBD患者特征提供了一个独特的人口统计数据.
研究的目的:
- 为了比较在内盖夫地区被诊断患有IBD的阿拉伯贝都因 (BA) 和犹太患者的临床特征和长期结果.
- 确定这两个族群之间疾病行为,治疗和医疗保健利用的潜在差异.
主要方法:
- 追溯病例对照研究,年龄和性别1:2匹配.
- 纳入标准:18岁以上的患者,诊断为克罗恩病 (CD) 或性结肠炎 (UC).
- 收集的数据:人口统计,疾病行为,治疗,医疗保健利用率和死亡率.
主要成果:
- 与犹太患者相比,BACD患者的内皮病比例更高,医疗保健利用率更低 (ED访问和住院次更少).
- 与犹太患者相比,患有CD或UC的BA患者接受生物治疗的频率较低.
- 与犹太患者相比,BA UC患者的肠直肠炎,肠外表现和住院和死亡率更高.
结论:
- 在BA和犹太IBD患者之间存在疾病表现,治疗和结果的显著差异.
- 这些发现突出了对文化敏感,量身定制的医疗保健策略的需要,以改善BA IBD患者的获取和支持.
- 解决医疗保健差异对于优化这一群体的长期结果至关重要.
更多相关视频
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
424
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
424
01:17Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
01:30Inflammatory Bowel Disease II: Crohn's Disease
390
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
390
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
329
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
329
01:29Inflammatory Bowel Disease IV: Pharmacological Management
196
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
196
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203